Other

Common stock, shares authorized (in shares)

Idexx Laboratories Common stock, shares authorized (in shares) remained flat by 0.0% to 120M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 120M to 120M. Over 5 years (FY 2020 to FY 2025), Common stock, shares authorized (in shares) shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025

How to read this metric

An increase indicates that shareholders have approved a higher ceiling for potential future equity issuance, often for capital raises or stock-based compensation.

Detailed definition

This represents the maximum number of common shares that a corporation is legally permitted to issue under its articles...

Peer comparison

Standard corporate governance metric; companies often maintain a buffer between authorized and outstanding shares.

Metric ID: other_common_stock_shares_authorized

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M120M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
Range120M120M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth

Common stock, shares authorized (in shares) at Other Companies

Frequently Asked Questions

What is Idexx Laboratories's common stock, shares authorized (in shares)?
Idexx Laboratories (IDXX) reported common stock, shares authorized (in shares) of 120M in Q1 2026.
How has Idexx Laboratories's common stock, shares authorized (in shares) changed year-over-year?
Idexx Laboratories's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 120M to 120M.
What is the long-term trend for Idexx Laboratories's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Idexx Laboratories's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 120M to 120M.
What does common stock, shares authorized (in shares) mean?
The maximum number of shares the company is legally allowed to issue.